NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 15,070
-540 (-3.46%)
At close: Oct 22, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 171.32 billion as of October 22, 2026. It is the 23,298th most valuable company in the world and the 914th biggest in South Korea. Its market cap has decreased by 63.45% in one year.
Market Cap
171.32B
Enterprise Value
158.72B
Revenue
22.60B
Global Rank
Country Rank
#914 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 171.32B, an increase of 357.66%. That is a compound annual growth rate of 10.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 171.32B | -59.84% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 254.77B |
| Genome & Company | 220.44B |
| IMBiologics | 213.20B |
| curacle co.,ltd. | 200.08B |
| Kangstem Biotech | 185.76B |
| ISU Abxis | 155.35B |
| Bio Solution | 152.76B |
| Kanaph Therapeutics | 140.19B |